Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Healthspan Biotics is a biotechnology and longevity-focused company that develops precision microbiome solutions and molecular supplements designed to extend human healthspan. The company's scientific framework is based on the 'Kaufmann Protocol,' which identifies and targets seven distinct molecular pathways of aging, including DNA repair, mitochondrial health, and sirtuin activation. By leveraging advanced research into the gut-brain-aging axis, Healthspan Biotics formulates specialized probiotics and nutraceuticals that aim to optimize cellular function and systemic resilience. Their products are engineered to address the fundamental drivers of biological decay, positioning the company at the intersection of pharmaceutical-grade science and consumer longevity interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Healthspan Biotics.